Judd H. Fastenberg

Judd H. Fastenberg

Auto-generated profile, based on publicly available information

Judd H. Fastenberg

Department of Otolaryngology-Head & Neck Surgery, Thomas Jefferson University Hospital, Philadelphia, PA

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2016 in World Journal of Otorhinolaryngology - Head and Neck Surgery
Verified
Journal Article
Open access
JFJudd H. Fastenberg
Judd H. Fastenberg
WHWayne D. Hsueh
Wayne D. Hsueh
AMAli Mustafa
Ali Mustafa
NANadeem A. Akbar
Nadeem A. Akbar
WAWaleed M. Abuzeid
Waleed M. Abuzeid
Background: There is increasing evidence that biofilms are critical to the pathophysiology of chronic infections including chronic rhinosinusitis (CRS). Until relatively recently, our understanding of biofilms was limited. Recent advances in methods for biofilm identification and molecular biology have offered new insights into the role of biofilms in CRS. With these insights, investigators have begun to investigate novel therapeutic strategies that may disrupt or eradicate biofilms in CRS.Objective: This review seeks to explore the evidence implicating biofilms in CRS, discuss potential anti‐biofilm therapeutic strategies, and suggest future directions for research.Results: The existing evidence strongly supports the role of biofilms in the pathogenesis of CRS. Several anti‐biofilm therapies have been investigated for use in CRS and these are at variable stages of development. Generally, these strategies: 1) neutralize biofilm microbes; 2) disperse existing biofilms; or 3) disrupt quorum sensing. Several of the most promising anti‐biofilm therapeutic strategies are reviewed.Conclusions: A better understanding of biofilm function and their contribution to the CRS disease process will be pivotal to the development of novel treatments that may augment and, potentially, redefine the CRS treatment paradigm. There is tremendous potential for future research.

16 October 2018 in Otolaryngology–Head and Neck Surgery
Verified
Journal Article
Closed access
PDF file
TTTheresa Tharakan
Theresa Tharakan
SJSydney Jiang
Sydney Jiang
JFJudd Fastenberg
Judd Fastenberg
TOThomas J. Ow
Thomas J. Ow
BSBradley Schiff
Bradley Schiff
VMVikas Mehta
Vikas Mehta

14 January 2020 in Allergy & Rhinology
Verified
Journal Article
Open access
PDF file
RRRyan A. Rimmer
Ryan A. Rimmer
AGAlexander E. Graf
Alexander E. Graf
JFJudd H. Fastenberg
Judd H. Fastenberg
JBJurij Bilyk
Jurij Bilyk
GNGurston G. Nyquist
Gurston G. Nyquist
MRMindy R. Rabinowitz
Mindy R. Rabinowitz
The endoscopic endonasal approach to management of orbital pathology has expanded. Due to the rarity of these conditions, most reports in the literature consist of small case reports. We report a series from a single institution with a focus on outcomes. A retrospective chart review was carried out between 2010 and 2018. Twenty-four patients were identified (average age 58 years, 15 males, 9 females). Average follow-up was 14.9 months. Most common etiologies included cavernous hemangioma (7), metastases (6), idiopathic orbital inflammatory syndrome (6), orbital hematoma/clot (2), and schwannoma (1). Most common presenting symptoms were decreased visual acuity (8), proptosis (8), diplopia (7), and incidental findings (2). All patients underwent endoscopic medial wall orbital decompressions. Sixteen involved a combined open approach by an ophthalmologist. Pathology was either biopsied (15), resected (6), or could not be identified (3). No intraoperative complications were noted. No patients underwent orbital reconstruction of the medial wall. Six patients developed postoperative sinusitis successfully managed with antibiotics. One patient developed epistaxis managed conservatively. In 5 patients, Sino-Nasal Outcome Test-22 scores increased immediately postop and then decreased, whereas scores only decreased in 6 patients. Six patients noted reduced proptosis. There were no new cases of diplopia or worsening visual acuity. A combined endoscopic endonasal and external approach can be useful for managing orbital lesions. Patients tolerated the procedure well with improvement in ocular symptoms and minimal sinonasal complications. Reconstruction of the medial wall may not be warranted to prevent postoperative diplopia.

6 December 2017 in International Forum of Allergy & Rhinology
Verified
Journal Article
Closed access
PDF file
WAWaleed M. Abuzeid
Waleed M. Abuzeid
MVMayand Vakil
Mayand Vakil
JLJuan Lin
Juan Lin
JFJudd Fastenberg
Judd Fastenberg
NANadeem A. Akbar
Nadeem A. Akbar
CFChristina H. Fang
Christina H. Fang

3 May 2020 in International Forum of Allergy & Rhinology
Verified
Journal Article
Closed access
PDF file
SVSwar Vimawala
Swar Vimawala
CCChandala Chitguppi
Chandala Chitguppi
ERErin Reilly
Erin Reilly
JFJudd H. Fastenberg
Judd H. Fastenberg
TGTomas Garzon‐Muvdi
Tomas Garzon‐Muvdi
GNGurston G. Nyquist
Gurston G. Nyquist

29 November 2017 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
WAWaleed M. Abuzeid
Waleed M. Abuzeid
CSChangeun Song
Changeun Song
JFJudd H. Fastenberg
Judd H. Fastenberg
CFChristina H. Fang
Christina H. Fang
NANoel Ayoub
Noel Ayoub
PHPeter H. Hwang
Peter H. Hwang